Adial Pharmaceuticals Valuation Multiples
Discover Adial Pharmaceuticals' revenue and EBITDA valuation multiples and M&A history.
Adial Pharmaceuticals Overview
About Adial Pharmaceuticals
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
Founded
2010
HQ
Employees
7
Website
Financials (LTM)
EV
$6M
Valuation Multiples
Start free trial
Adial Pharmaceuticals Financials
Adial Pharmaceuticals reported last 12-month revenue of -.
In the same LTM period, Adial Pharmaceuticals generated - in gross profit and had net loss of ($10M).
Revenue (LTM)
Adial Pharmaceuticals P&L
In the most recent fiscal year, Adial Pharmaceuticals reported revenue of - and EBITDA of ($8M).
Adial Pharmaceuticals is unprofitable as of last fiscal year, with gross margin of -, EBITDA margin of -, and net margin of -.
Financial data powered by Morningstar, Inc.
Adial Pharmaceuticals Stock Performance
Adial Pharmaceuticals has current market cap of $11M, and enterprise value of $6M.
Market Cap Evolution
Adial Pharmaceuticals' stock price is $4.91.
Adial Pharmaceuticals share price increased by 45.7% in the last 30 days, and decreased by 48.3% in the last year.
Adial Pharmaceuticals has an EPS (earnings per share) of $-3.65.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $6M | $11M | 19.8% | 45.7% | 107.2% | -48.3% | $-3.65 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAdial Pharmaceuticals Valuation Multiples
Adial Pharmaceuticals trades at (0.8x) EV/EBITDA.
Adial Pharmaceuticals Financial Valuation Multiples
As of August 7, 2026, Adial Pharmaceuticals has market cap of $11M and EV of $6M.
Adial Pharmaceuticals has a P/E ratio of (1.1x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Adial Pharmaceuticals Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Adial Pharmaceuticals Margins & Growth Rates
Adial Pharmaceuticals grew net profit by 46% in the last fiscal year.
Adial Pharmaceuticals Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Adial Pharmaceuticals Operational KPIs
Adial Pharmaceuticals' revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $1.1M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Adial Pharmaceuticals Competitors
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
This data is available for Pro users. Sign up to see all Adial Pharmaceuticals competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Adial Pharmaceuticals
Adial Pharmaceuticals has acquired 1 company to date.
Last acquisition by Adial Pharmaceuticals was on June 10th 2026. Adial Pharmaceuticals acquired Azora Therapeutics for undisclosed valuation.
Latest Acquisitions by Adial Pharmaceuticals
| Description | Azora Therapeutics is a San Diego-based biopharmaceutical company developing oral small-molecule therapies for inflammatory diseases. Its lead candidate AZT-001 targets hidradenitis suppurativa and ulcerative colitis through inhibition of specific inflammatory pathways. The company advances candidates from preclinical stages through Phase 2 trials, leveraging proprietary chemistry platforms for autoimmune conditions. Founded in 2021, Azora collaborates with contract research organizations in the US and Europe for clinical development. |
| HQ Country |  |
| HQ City | Los Angeles, CA |
| Deal Date | 10 Jun 2026 |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Adial Pharmaceuticals acquisitions and their M&A valuation multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Adial Pharmaceuticals
| When was Adial Pharmaceuticals founded? | Adial Pharmaceuticals was founded in 2010. |
| Where is Adial Pharmaceuticals headquartered? | Adial Pharmaceuticals is headquartered in United States. |
| How many employees does Adial Pharmaceuticals have? | As of today, Adial Pharmaceuticals has over 7 employees. |
| Is Adial Pharmaceuticals publicly listed? | Yes, Adial Pharmaceuticals is a public company listed on Nasdaq. |
| What is the stock symbol of Adial Pharmaceuticals? | Adial Pharmaceuticals trades under ADIL ticker. |
| When did Adial Pharmaceuticals go public? | Adial Pharmaceuticals went public in 2018. |
| Who are competitors of Adial Pharmaceuticals? | Adial Pharmaceuticals main competitors include |
| What is the current market cap of Adial Pharmaceuticals? | Adial Pharmaceuticals' current market cap is $11M. |
| Is Adial Pharmaceuticals profitable? | No, Adial Pharmaceuticals is not profitable. |
| What is the current net income of Adial Pharmaceuticals? | Adial Pharmaceuticals' last 12 months net income is ($10M). |
| How many companies Adial Pharmaceuticals has acquired to date? | As of August 2026, Adial Pharmaceuticals has acquired 1 company. |
| What was the largest acquisition by Adial Pharmaceuticals? | None of the M&A deals Adial Pharmaceuticals has completed have disclosed valuations. |
| What companies Adial Pharmaceuticals acquired? | Adial Pharmaceuticals acquired Azora Therapeutics. |
| In how many companies Adial Pharmaceuticals has invested to date? | Adial Pharmaceuticals hasn't invested in any companies yet (or none have been disclosed publicly). |
Lists including Adial Pharmaceuticals
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.